0 of 8 Questions completed
Questions:
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 8 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Hepatocellular carcinoma (HCC) accounts for ______________ of all primary liver cancers and is a significant cause of morbidity and mortality worldwide.
Liver transplantation remains the best curative option for individuals with limited HCC—eg, one tumor < 5 cm in diameter or 3 tumors each < 3 cm in diameter, comprising the Milan criteria.
Carcinoid tumors represent the most common neuroendocrine tumors and typically arise in the pulmonary system or gastrointestinal tract.
Colorectal carcinoma (CRC) is the ________ most common cancer in the United States, and it is the second most frequent cause of cancer-related death.
Which term is defined as infusion of single or multiple chemotherapeutic agents with or without ethiodized oil with or without concurrent (as a component of the chemoembolic emulsion) or tandem embolization with particles such as gelatin sponge, polyvinyl alcohol, or calibrated microspheres.
What term is defined by control or elimination of cancer-related symptoms (as in patients with symptomatic, hormone-secreting NETs) or by clinical outcome improvement quantified using standard oncologic measures such as OS, PFS, or TTP (as in tumors such as HCC and CLM)?
Of The listed adverse events from Transarterial Chemoembolization and Embolization, what is the only one with a reported rate higher then 1%?
Technical success should be attainable in the vast majority of cases. The threshold for transarterial chemoembolization and embolization technical success is ____%. When technical success rates fall below this threshold, operators should consider reviewing institutional procedural methodology.